Top Markets
#1 DogBull DogBull +107.30%
#2 MarsCoin MarsCoin +62.81%
#3 Siacoin Siacoin +51.84%
#4 ADO Protocol ADO Protocol +51.50%
#5 Ontology Gas Ontology Gas +24.09%
#6 The Bitcoin Bull The Bitcoin Bull +17.18%
#7 Useless Coin Useless Coin +14.86%
#8 Apertum Apertum +14.84%
#9 Nockchain Nockchain +12.03%
#10 UnifAI Network UnifAI Network +11.58%
Coin of the day
DogBull DogBull
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Pozycja w akcjach #15114
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Cena akcji
$4.74
Ostatnia synchronizacja: 2026-08-31
Kapitalizacja rynkowa
$372.19M
Zmiana (1 dzień)
-2.47%
Zmiana (1 rok)
-1.04%
Kraj
US
Handel Lexeo Therapeutics, Inc. Common Stock (LXEO)

Kategoria

Healthcare
Zyski dla Lexeo Therapeutics, Inc. Common Stock (LXEO)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Lexeo Therapeutics, Inc. Common Stock, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Lexeo Therapeutics, Inc. Common Stock od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH